Our vision is to be the number one healthcare company in South Africa with a focus on medicinal Cannabis. To utilize current skills and build on new skills to deliver world class products. Execute product and process innovation through to market consumption and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and wellness cannabis consumers the best possible solution.
Cannabis stocks are a performer of note – Labat Healthcare will lead the way in South Africa. — The initial feasibility study identified the impact that Labat Healthcare will have on the local and national economy and very importantly, the significant contribution to employment opportunities and the value creation to its shareholders. The plan is to play a leading role in the development of the SA Industrial Hemp and Medical Cannabis Industry with a focus on value creation in the economy.
The business fundamentals are based on a vertically integrated value chain operating from Cannabis seed to Pharmaceutical Active Pharmaceutical Ingredient sales, as well as supply and distribution of finished dose form for the Complementary Medicines Industry. — The proposed business model covers the entire value chain – from planting the seeds to brand retail sales. The plan is to grow Labat’s own brand of recreational and medicinal cannabis called Knuckle Genetics (a high THC content of plus 30%) for supply to international markets.
Labat Pharmaceuticals will extract THC and CBD oils and purify these raw materials to world class Active Pharmaceutical Ingredients quality – these products will have Drug Master Files registered worldwide and we will thus ensure international Regulatory Approvals.
Mike worked 30 years in the API industry and the last five years as CEO. He was key in developing the USA and EU markets together with highly competent Agents. Mike initially studied Chemical Engineering whilst working in the laboratory but was eventually persuaded to transfer to the commercial part of the business. Procurement & Supply Chain and eventually Business Development was part of his previous roles and due to outstanding performance was rewarded with the position of CEO for one of the world’s top API manufacturers. Mike subsequently completed his Executive Leadership Programme at the UCT Graduate School of Business and then his MBA in Leadership and Sustainability in the UK. Mike brings with the essential API experience – regulatory, technical expertise and business development knowledge.
Herschel is an entrepreneur, with a primary degree in the UWC Faculty of Community & Health Sciences, and Postgraduate qualifications in Development Economics (UWC) and Logistics (University of Ecuador & University of Liege). His strengths are in Strategic Planning, Stakeholder Analysis, Business Management and Project Management. He served as Project Director of International Benchmarking for Chemical Industries at CHIETA as well as Project Director for Marketing and Feasibility Studies for the Dutch organisation EVD (international cooperation & economic development). He Previously served as Chairman of the Nelson Mandela Presidential Jobs Summit on the SMME Implementation Committee, the Chairman of the Dutch Chamber of Commerce and as Chairman of the National Committee for the Assessment of Reforms of Public Procurement to the SMME sector in South Africa.
Stanton Van Rooyen has been working for Labat Africa Limited for seven years holding a variety of positions most recently business development manager of the Labat Africa Limited group, he set up the logistics division of Labat, and is currently the CEO of Labat Bulk Logistics. Stanton will bring with business development and management knowledge and experience.